Diagnostic performance of Hybrid Capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study

American Journal of Obstetrics and Gynecology

Volumn 175, Issue 3 PART I, 1996, Pages 651-656

  Ferenczy, Alex ^a   Franco, Eduarde ^b   Arseneau, Jocelyne ^b   Wright, Thomas C ^c   Richart, Ralph M ^c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Royal Victoria Hospital ^*

Author keywords

Diagnostic performance; Hybrid capture human papillomavirus deoxyribonucleic acid assay; Liquid based thin prep cytologic study

Indexed keywords

ARTICLE; CANCER GRADING; CANCER SCREENING; COLPOSCOPY; CYTOLOGY; DIAGNOSTIC TEST; DNA DETERMINATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COLPOSCOPY; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; VAGINAL SMEARS;

EID: 0029803662     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1053/ob.1996.v175.a73868     Document Type: Article

References (13)

1. International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papilloma viruses. Lyon (France) : IARC Scientific, 1995.
2. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79:328-37.
3. Ho GYF, Burk RD, Klein S, Radish AS, Chang CJ, Palan P, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-71.
4. Schiffman MH. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 1992;84:394-8.
5. Koss LG. Cervical (Pap) smear: new directions. Cancer 1993;71:1406-12.
6. Ferenczy A. Viral testing for genital human papillomavirus infections: recent progress and clinical potentials. Int J Gynecol Cancer 1995;5:321-8.
7. Sherman ME, Schiffman MH, Lorincz AT, Manos MM, Scott DR, Kurman RJ, et al. Toward objective quality assurance in cervical cytopathology: correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. Am J Clin Pathol 1994;102:182-7.
8. Wright TC, Sun XW, Koulos J. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol 1995;85:202-10.
9. Ferenczy A, Robitaille J, Franco E, Arseneau J, Richart RM, Wright TC. Conventional cervical cytologic smears vs. Thin-Prep smears: a paired comparison study on cervical cytology. Acta Cytol 1996. In press.
10. Hutchinson ML, Agarwal P, Denault T, Berger B, Cibas ES. A new look at cervical cytology: Thinprep multicenter trial results. Acta Cytol 1992;36:499-504.
11. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture is useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995;172:946-54.
12. Cox JT, Schiffman MH, Winzelberg AJ, Patterson JM. An evaluation of human papillomavirus testing as part of referral to colposcopy clinics. Obstet Gynecol 1992;80:389-95.
13. Baldauf J-J, Dreyfus M, Lehmann M, Ritter J, Philippe E. Cervical cancer screening with cervicography and cytology. Eur J Obstet Gynecol Reprod Biol 1995;58:33-9.